Drivers of AR indifferent anti-androgen resistance in prostate cancer cells.

Drivers of AR indifferent anti-androgen resistance in prostate cancer cells.

Inhibition of the androgen receptor (AR) by second-generation anti-androgens is a standard treatment for metastatic castration resistant prostate cancer (mCRPC), but it inevitably leads to the development of resistance. Since the introduction of highly efficient AR signalling inhibitors, approximate...

Full description

Bibliographic Details
Main Authors:	Handle, F, Prekovic, S, Helsen, C, Van Den Broeck, T, Smeets, E, Moris, L, Eerlings, R, Kharraz, SE, Urbanucci, A, Mills, IG, Joniau, S, Attard, G, Claessens, F
Format:	Journal article
Language:	English
Published:	Nature Research 2019

Similar Items

Antiandrogen-Equipped Histone Deacetylase Inhibitors Selectively Inhibit Androgen Receptor (AR) and AR-Splice Variant (AR-SV) in Castration-Resistant Prostate Cancer (CRPC)
by: Chandrasekaran, Balaji, et al.
Published: (2023)

The role of the androgen receptor as a driver and mitigator of cellular stress
by: Doultsinos, D, et al.
Published: (2020)

c-Myc antagonises the transcriptional activity of the androgen receptor in prostate cancer affecting key gene networks.
by: Barfeld, S, et al.
Published: (2017)

Independence of HIF1a and androgen signaling pathways in prostate cancer
by: Tran, MGB, et al.
Published: (2020)

ANTI-ANDROGENS IN TREATMENT OF PROSTATE-CANCER - REPLY
by: Dalesio, O, et al.
Published: (1995)

Androgen blockade in prostate cancer - Authors' reply
by: Dalesio, O, et al.
Published: (2000)

Utility indifference
by: Armstrong, S
Published: (2010)

Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse
by: Taavitsainen, S, et al.
Published: (2021)

Bromodomain-containing proteins in prostate cancer.
by: Urbanucci, A, et al.
Published: (2017)

VPRBP functions downstream of the androgen receptor and OGT to restrict p53 activation in prostate cancer
by: Poulose, N, et al.
Published: (2022)

Androgen receptor deregulation drives bromodomain-mediated chromatin alterations in prostate cancer.
by: Urbanucci, A, et al.
Published: (2017)

Can androgen receptor levels in the prostate predict non-organ-confined prostate cancer?
by: Hamdy, F
Published: (2005)

Mechanism of anti-cancer activity of curcumin on androgen-dependent and androgen-independent prostate cancer
by: Abd. Wahab, Nurul Azwa, et al.
Published: (2020)

CACNA1D overexpression and voltage-gated calcium channels in prostate cancer during androgen deprivation
by: McKerr, N, et al.
Published: (2023)

Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer.
by: Asim, M, et al.
Published: (2017)

The early effects of rapid androgen deprivation on human prostate cancer
by: Shaw, G, et al.
Published: (2015)

Anticancer imidazoacridinone C-1311 is effective in androgen-dependent and androgen-independent prostate cancer cells
by: Niemira, M, et al.
Published: (2020)

Sequencing the transcriptional network of androgen receptor in prostate cancer
by: Chng, Kern Rei, et al.
Published: (2013)

Systemic interrogation of immune-oncology-related proteins in patients with locally advanced prostate cancer undergoing androgen deprivation and intensity-modulated radiotherapy
by: Guldvik, IJ, et al.
Published: (2024)

Glycosylation is an androgen-regulated process essential for prostate cancer cell viability.
by: Munkley, J, et al.
Published: (2016)

The problem of evil and moral indifference
by: Mawson, T
Published: (1999)

Electroreduction of nitromethane in aqueous solution. A surface indifferent electrocatalytic reaction
by: Aixill, W, et al.
Published: (1998)

Regulation of ADAMTS expression in prostate cancer and stromal cells by androgen and TNF
by: Molokwu, C, et al.
Published: (2007)

Androgen regulates ADAMTS15 gene expression in prostate cancer cells.
by: Molokwu, C, et al.
Published: (2010)

Androgens target prohibitin to regulate proliferation of prostate cancer cells.
by: Gamble, S, et al.
Published: (2004)

Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials
by: Dalesio, O, et al.
Published: (2000)

Insight into zone of indifference and power distance.
by: Chow, Shih Ling., et al.
Published: (2008)

Utility indifference pricing with market incompleteness
by: Monoyios, M
Published: (2008)

Is the universe indifferent? Should we care?
by: Kahane, G
Published: (2021)

TIMP-3 expression in prostate stromal and tumour cells is regulated by androgen and TNF
by: Adeniji, O, et al.
Published: (2007)

TIMP-3 expression is regulated by androgen and TNF in prostate stromal and cancer cells
by: Adeniji, O, et al.
Published: (2008)

Emerging frontiers in androgen receptor research for prostate Cancer: insights from the 2nd international androgen receptor Symposium
by: Israel, JS, et al.
Published: (2024)

Androgen manipulation alters oxidative DNA adduct levels in androgen-sensitive prostate cancer cells grown in vitro and in vivo.
by: Pathak, S, et al.
Published: (2008)

The androgen receptor induces a distinct transcriptional program in castration resistant prostate cancer in man
by: Sharma, N, et al.
Published: (2012)

NF-kappaB regulates androgen receptor expression and prostate cancer growth.
by: Zhang, L, et al.
Published: (2009)

A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growth
by: Gillis, JL, et al.
Published: (2021)

The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man.
by: Sharma, N, et al.
Published: (2013)

Autocrine activation of MAPK signaling mediates intrinsic tolerance to androgen deprivation in LY6D prostate cancer cells
by: Steiner, I, et al.
Published: (2023)

Forward performance measurement with applications in indifference valuation
by: Yusong, L, et al.
Published: (2014)

Indifference to past human rights violations in Chile
by: Corral, H
Published: (2017)